1. Vrednotenje imunske modulacije in učinkovitosti agonista receptorja EP4 in monoklonskih protiteles in vitroTijana Markovič, 2018, doctoral dissertation Keywords: zdravilne učinkovine, imunomodulatorno delovanje, vrednotenje, metode, limfoblastoidne celične linije, receptor EP4, agonisti, limfom, monoklonska protitelesa, levkemija celic B Full text (file, 4,22 MB) |
2. EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cellsSanja Nabergoj, Tijana Markovič, Damjan Avsec, Martina Gobec, Helena Podgornik, Žiga Jakopin, Irena Mlinarič-Raščan, 2021, original scientific article Keywords: chronic lymphocytic leukemia, L-902688, NF-κB inhibition, prostaglandin E4, receptor, synergistic cytotoxic activity, prostaglandin E4 receptor Full text (file, 3,50 MB) This document has more files! More... |
|
|
5. The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodiesTijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan, 2022, original scientific article Keywords: B-cell leukemia and lymphoma, chronic lymphocytic leukemia, prostaglandin EP4 receptor, selective EP4 receptor agonist, monoclonal antibodies, synergistic effects Full text (file, 1,90 MB) This document has more files! More... |
6. Sinergistično delovanje ibrutiniba in idelalisiba z agonisti receptorja EP4 na celicah kronične limfocitne levkemijeDamjan Avsec, 2018, master's thesis Keywords: kronična limfocitna levkemija, ibrutinib, fludarabin, sinergizem, idelalisib, L-902, 688, PgE1-OH, prostaglandinski receptor tipa 4 (Ep4) Full text (file, 2,62 MB) |
|
|
9. Vrednotenje celičnih modelov za določanje sproščanja proinflamatornih citokinovJure Kuzma, 2023, master's thesis/paper Keywords: celični modeli, konstitutivni proteasom, imunoproteasom, citokinska nevihta, citokini, NF-κB, zaviralci proteasoma in imunoproteasoma Full text (file, 8,16 MB) |
10. Preučevanje sinergističnih učinkov agonistov prostaglandinskega receptorja EP4 z venetoklaksom, akalabrutinibom in duvelizibom in vitroNastja Bejek, 2023, master's thesis/paper Keywords: kronična limfocitna levkemija (KLL), prostaglandinski receptor tipa 4 (EP4), L-902, 688, PgE1-OH, KAG-308, venetoklaks, ibrutinib, akalabrutinib, idelalizib, duvelizib, sinergizem Full text (file, 1,85 MB) |